Max Chat
Company Analysis ORIC Pharmaceuticals, Inc.
1. Summary
Advantages
- Price (9.58 $) is less than fair price (10.49 $)
Disadvantages
- Dividends (0%) are below the sector average (0.527%).
- The stock's return over the last year (-4.1%) is lower than the sector average (0%).
- Current debt level 1.16% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-54.73%) is lower than the sector average (ROE=14.17%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| ORIC Pharmaceuticals, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 2.8% | 0% | 1.1% |
| 90 days | 104.3% | 3.4% | 21.6% |
| 1 year | -4.1% | 0% | 11.8% |
ORIC vs Sector: ORIC Pharmaceuticals, Inc. has slightly underperformed the "Healthcare" sector by -4.1% over the past year.
ORIC vs Market: ORIC Pharmaceuticals, Inc. has significantly underperformed the market by -15.87% over the past year.
Slightly volatile price: ORIC is more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: ORIC with weekly volatility of -0.0789% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (9.58 $) is lower than the fair price (10.49 $).
Price not significantly lower than the fair price: The current price (9.58 $) is slightly lower than the fair price by 9.5%.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (64.31).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (89.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.31) is lower than that of the sector as a whole (18.97).
P/BV vs Market: The company's P/BV (2.31) is lower than that of the market as a whole (9.37).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (32.77).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (10.11).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-4) is lower than that of the sector as a whole (274.86).
EV/Ebitda vs Market: The company's EV/Ebitda (-4) is lower than that of the market as a whole (51.19).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 14.55% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (14.55%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-15.75%).
5.4. ROE
ROE vs Sector: The company's ROE (-54.73%) is lower than that of the sector as a whole (14.17%).
ROE vs Market: The company's ROE (-54.73%) is lower than that of the market as a whole (11.64%).
5.5. ROA
ROA vs Sector: The company's ROA (-48.6%) is lower than that of the sector as a whole (1.18%).
ROA vs Market: The company's ROA (-48.6%) is lower than that of the market as a whole (6.89%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-32.1%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (-32.1%) is lower than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.527%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
